Ethical perspectives on relations between industry and neuropsychiatric medicine

References

• Bair B. Presentation and recognition of common psychiatric disorders in the elderly. Clinical Geriatrics 2000; 8: 26–48
   Google Scholar
• Bair BD. Frequently missed diagnosis in geriatric psychiatry. The Psychiatric Clinics of North America 1998; 21: 941–971, viii
   PubMed Web of Science ®Google Scholar
• Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW. Quantitative analysis of sponsorship bias in economic studies of antidepressants. British Journal of Psychiatry 2003; 183: 498–506
   PubMed Web of Science ®Google Scholar
• Barry LK. Ethical issues in psychiatric research. The Psychiatric Clinics of North America 2009; 32: 381–394
   PubMed Web of Science ®Google Scholar
• Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug–drug comparisons: why some statins appear more efficacious than others. Public Library of Science- Medicine 2007; 4: e184
   Google Scholar
• Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. Journal of the American Medical Association 2003; 289: 454–465
   PubMed Web of Science ®Google Scholar
• Bošnjak S. The Declaration of Helsinki - The cornerstone of research ethics. Archives of Oncology 2001; 9: 179–184
   Google Scholar
• Burn DJ. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Movement Disorders 2002; 17: 445–454
   PubMed Web of Science ®Google Scholar
• Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: A meta-analysis. International Clinics of Psychopharmacology 2007; 22: 159–166
   PubMed Web of Science ®Google Scholar
• Di Iulio F, Palmer K, Blundo C, Casini AR, Gianni W, Caltagirone C, et al, (2010). Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes. International Psychogeriatrics, 22:629–640
   Google Scholar
• Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, et al. The uncertainty principle and industry-sponsored research. Lancet 2000; 356: 635–638
   PubMed Web of Science ®Google Scholar
• Fava GA, Kellner R, Perini GI, Fava M, Michelacci L, Munari F, et al. Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). Canadian Journal of Psychiatry 1983; 28: 117–123
   PubMed Web of Science ®Google Scholar
• Fisher JA. Co-ordinating ‘ethical’ clinical trials: The role of research coordinators in the contract research industry. Sociology of Health & Illness 2006; 28: 678–694
   PubMed Web of Science ®Google Scholar
• Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. Journal of the American Medical Association 1999; 282: 1453–1457
   PubMed Web of Science ®Google Scholar
• Gabaldon L, Fuentes B, Frank-Garcia A, Diez-Tejedor E. Poststroke depression: Importance of its detection and treatment. Cerebrovascular Diseases 2007; 24: S181–188
   PubMedGoogle Scholar
• Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: A systematic review of observational studies. Stroke 2005; 36: 1330–1340
   PubMed Web of Science ®Google Scholar
• Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. American Journal of Psychiatry 2006; 163: 185–194
   PubMed Web of Science ®Google Scholar
• Jacobson S, Pies R, Katz I, (2007). Clinical manual of geriatric psychopharmacology. Washington, DC: American Psychiatric Publishing
   Google Scholar
• Jorge R, Robinson RG. Mood disorders following traumatic brain injury. International Review of Psychiatry 2003; 15: 317–327
   PubMed Web of Science ®Google Scholar
• Kessler RC, Angermeyer M, Anthony JC, de Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007; 6: 168–176
   PubMed Web of Science ®Google Scholar
• Kessler RC, Birnbaum HG, Shahly V, Bromet E, Hwang I, McLaughlin KA, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: Results from the WHO World Mental Health Survey Initiative. Depression and Anxiety 2010; 27: 351–364
   PubMed Web of Science ®Google Scholar
• Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. British Medical Journal 2002; 325: 249–252
   PubMed Web of Science ®Google Scholar
• Knox KS, Adams JR, Djulbegovic B, Stinson TJ, Tomor C, Bennet CL. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology. Annals of Oncology 2000; 11: 1591–1595
   PubMed Web of Science ®Google Scholar
• Komesaroff P, Carney S, La Brooy J, Tattersall M, Greenberg P, Bruce A, et al. Guidelines for the Relationships Involving Medical Practitioners and Industry. RACP, Sydney 2005
   Google Scholar
• Lemke MR, Fuchs G, Gemende I, Herting B, Oehlwein C, Reichmann H, et al. Depression and Parkinson's disease. Journal of Neurology 2004; 251: SVI/24–27
   Google Scholar
• Lenzi GL, Altieri M, Maestrini I. Post-stroke depression. Revue Neurologique (Paris) 2008; 164: 837–840
   PubMed Web of Science ®Google Scholar
• Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal 2003; 326: 1167–1170
   PubMed Web of Science ®Google Scholar
• Lindsey PL. Psychotropic medication use among older adults: What all nurses need to know. Journal of Gerontological Nursing 2009; 35: 28–38
   PubMed Web of Science ®Google Scholar
• Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's disease: Report of a NINDS/NIMH Work Group. Movement Disorders 2006; 21: 148–158
   PubMed Web of Science ®Google Scholar
• Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009; 72: 886–892
   PubMed Web of Science ®Google Scholar
• Norman S, Troster AI, Fields JA, Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. Journal of Neuropsychiatry and Clinical Neuroscience 2002; 14: 31–36
   PubMed Web of Science ®Google Scholar
• OHSR (1979). The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. http://ohsr.od.nih.gov/guidelines/belmont.html#top
   Google Scholar
• Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. American Journal of Psychiatry 2005; 162: 1957–1960
   PubMed Web of Science ®Google Scholar
• Poewe W, Seppi K. Treatment options for depression and psychosis in Parkinson's disease. Journal of Neurology 2001; 248: SIII12–21
   Google Scholar
• Potter GG, Steffens DC. Contribution of depression to cognitive impairment and dementia in older adults. Neurologist 2007; 13: 105–117
   PubMed Web of Science ®Google Scholar
• Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Movement Disorders 2008; 23: 183–189; quiz 313
   PubMed Web of Science ®Google Scholar
• Roberts L, Dyer A. A Concise Guide to Ethics in Mental Health Care. American Psychiatric Publishing, Washington, DC 2004
   Google Scholar
• Robinson RG. Poststroke depression: Prevalence, diagnosis, treatment, and disease progression. Biological Psychiatry 2003; 54: 376–387
   PubMed Web of Science ®Google Scholar
• Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: A randomized controlled trial. Journal of the American Medical Association 2008; 299: 2391–2400
   PubMed Web of Science ®Google Scholar
• Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, et al. Sertraline for the treatment of depression in Alzheimer disease. American Journal of Geriatric Psychiatry 2010; 18: 136–145
   PubMed Web of Science ®Google Scholar
• Scott KM, Von Korff M, Alonso J, Angermeyer M, Bromet EJ, Bruffaerts R, et al. Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical co-morbidity. Psychological Medicine 2008; 38: 1659–1669
   PubMed Web of Science ®Google Scholar
• Segman R, Weizman A. Drug industry, psychopharmacology, and mental health care needs: Where do we go from here?. Israel Journal of Psychiatry and Related Sciences 2008; 45: 71–79
   PubMed Web of Science ®Google Scholar
• Spalletta G, Caltagirone C. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms. Functional Neurology 2003; 18: 227–232
   PubMed Web of Science ®Google Scholar
• Spalletta G, Caltagirone C. Depression and other neuropsychiatric complications after stroke. Stroke Recovery and Rehabilitation, J Stein, R Zorowitz, R Harvey, R Macko, C Winstein. Demos Medical Publishing, New York 2008
   Google Scholar
• Spalletta G, Guida G, Caltagirone C. Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?. Journal of Neurology 2003; 250: 449–455
   PubMed Web of Science ®Google Scholar
• Spalletta G, Ripa A, Bria P, Caltagirone C, Robinson RG. Response of emotional unawareness after stroke to antidepressant treatment. Americal Journal of Geriatric Psychiatry 2006; 14: 220–227
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mizrahi R, Power BD. Antidepressant therapy in post-stroke depression. Expert Opinions in Pharmacotherapy 2008a; 9: 1291–1298
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mizrahi R, Power BD. Depression in Alzheimer's disease: Phenomenology, clinical correlates and treatment. International Review of Psychiatry 2008b; 20: 382–388
   PubMed Web of Science ®Google Scholar
• Taylor S, McCracken CF, Wilson KC, Copeland JR. Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. British Journal of Psychiatry 1998; 173: 433–438
   PubMed Web of Science ®Google Scholar
• Thompson S, Herrmann N, Rapoport MJ, Lanctot KL. Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: A metaanalysis. Canadian Journal of Psychiatry 2007; 52: 248–255
   PubMed Web of Science ®Google Scholar
• Timmermans S, Berg M. The practice of medical technology. Sociology of Health & Illness 2003; 25: 97–114
   PubMed Web of Science ®Google Scholar
• Tsuno N, Homma A. What is the association between depression and Alzheimer's disease?. Expert Review of Neurotherapics 2009; 9: 1667–1676
   PubMed Web of Science ®Google Scholar
• Tyebkhan G. The Declaration of Helsinki: The ethical cornerstone of human clinical research. Indian Journal of Dermatology 2003; 69: 245–247
   Google Scholar
• Ulas H, Binbay T, Alptekin K. [Financial conflict of interest in clinical psychiatry studies: A review]. Turk Psikiyatri Dergisi 2008; 19: 418–426
   PubMed Web of Science ®Google Scholar
• UN (2009). World Population Prospects: The 2008 Revision Population Database. United Nations. http://esa.un.org/UNPP/index.asp?panel=2
   Google Scholar
• Voyer P, Martin LS. Improving geriatricmental health nursing care: Making a case for going beyond psychotropic medications. International Journal of Mental Health Nursing 2003; 12: 11–21
   PubMed Web of Science ®Google Scholar
• Warner T, Gluck J. What do we really know about conflicts of interest in biomedical research?. Psychopharmacology 2003; 171: 36–46
   PubMed Web of Science ®Google Scholar
• Wastfelt M, Fadeel B, Henter JI. A journey of hope: Lessons learned from studies on rare diseases and orphan drugs. Journal of Internal Medicine 2006; 260: 1–10
   PubMed Web of Science ®Google Scholar
• WHO (1999). World HealthReport 1999 World Health Organization, Geneva.
   Google Scholar
• WHO (2008). The global burden of disease: 2004 update. World Health Organization, Geneva.
   Google Scholar
• WMA (2008). Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. World Medical Association. http://www.wma.net/en/30publications/10policies/b3/index.html
   Google Scholar
• Zubenko GS, Sunderland T. Geriatric psychopharmacology: Why does age matter?. Harvard Review of Psychiatry 2000; 7: 311–333
   PubMed Web of Science ®Google Scholar